{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:19:46Z","timestamp":1793729986368,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"},{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep07394","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T10:06:49Z","timestamp":1418119609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Olanzapine-induced weight gain plays a key role in the potential cardiovascular risk: evidence from heart rate variability analysis"],"prefix":"10.1038","volume":"4","author":[{"given":"Jun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-song","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-xian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-he","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,9]]},"reference":[{"key":"BFsrep07394_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","volume":"196","author":"S Brown","year":"2010","unstructured":"Brown, S., Kim, M., Mitchell, C. & Inskip, H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 196, 116\u2013121 (2010).","journal-title":"Br J Psychiatry"},{"key":"BFsrep07394_CR2","doi-asserted-by":"publisher","first-page":"e001810","DOI":"10.1136\/bmjopen-2012-001810","volume":"2","author":"D Healy","year":"2012","unstructured":"Healy, D. et al. Mortality in schizophrenia and related psychoses: data from two cohorts, 1875\u20131924 and 1994\u20132010. BMJ Open 2, e001810 (2012).","journal-title":"BMJ Open"},{"key":"BFsrep07394_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/08039480801959323","volume":"62","author":"H Koponen","year":"2008","unstructured":"Koponen, H. et al. Schizophrenia and sudden cardiac death: a review. Nord J Psychiatry 62, 342\u2013345 (2008).","journal-title":"Nord J Psychiatry"},{"key":"BFsrep07394_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.schres.2014.03.011","volume":"155","author":"P Ifteni","year":"2014","unstructured":"Ifteni, P., Correll, C. U., Burtea, V., Kane, J. M. & Manu, P. Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients. Schizophr Res 155, 72\u201376 (2014).","journal-title":"Schizophr Res"},{"key":"BFsrep07394_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1161\/CIRCULATIONAHA.114.008779","volume":"130","author":"ST Lin","year":"2014","unstructured":"Lin, S. T. et al. Association Between Antipsychotic Use and Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study. Circulation 130, 235\u2013243 (2014).","journal-title":"Circulation"},{"key":"BFsrep07394_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"WA Ray","year":"2009","unstructured":"Ray, W. A., Chung, C. P., Murray, K. T., Hall, K. & Stein, C. M. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360, 225\u2013235 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep07394_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.pharmthera.2012.04.003","volume":"135","author":"JY Leung","year":"2012","unstructured":"Leung, J. Y., Barr, A. M., Procyshyn, R. M., Honer, W. G. & Pang, C. C. Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system. Pharmacol Ther 135, 113\u2013122 (2012).","journal-title":"Pharmacol Ther"},{"key":"BFsrep07394_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2009.09.543","volume":"141","author":"JF Thayer","year":"2010","unstructured":"Thayer, J. F., Yamamoto, S. S. & Brosschot, J. F. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 141, 122\u2013131 (2010).","journal-title":"Int J Cardiol"},{"issue":"5","key":"BFsrep07394_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","volume":"93","author":"Task Force of the European Society Electrophysiology","year":"1996","unstructured":"Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043\u20131065 (1996).","journal-title":"Circulation"},{"key":"BFsrep07394_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/eurheartj\/ehn537","volume":"30","author":"HV Huikuri","year":"2009","unstructured":"Huikuri, H. V. et al. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J 30, 689\u2013698 (2009).","journal-title":"Eur Heart J"},{"key":"BFsrep07394_CR11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1440-1819.2009.01983.x","volume":"63","author":"M Fujibayashi","year":"2009","unstructured":"Fujibayashi, M. et al. Autonomic nervous system activity and psychiatric severity in schizophrenia. Psychiatry Clin Neurosci 63, 538\u2013545 (2009).","journal-title":"Psychiatry Clin Neurosci"},{"key":"BFsrep07394_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.9758\/cpn.2013.11.3.137","volume":"11","author":"E Moon","year":"2013","unstructured":"Moon, E., Lee, S. H., Kim, D. H. & Hwang, B. Comparative Study of Heart Rate Variability in Patients with Schizophrenia, Bipolar Disorder, Post-traumatic Stress Disorder, or Major Depressive Disorder. Clin Psychopharmacol Neurosci 11, 137\u2013143 (2013).","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"BFsrep07394_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jpsychires.2004.12.007","volume":"39","author":"KJ Bar","year":"2005","unstructured":"Bar, K. J. et al. Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res 39, 519\u2013527 (2005).","journal-title":"J Psychiatr Res"},{"key":"BFsrep07394_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0167-8760(98)00047-6","volume":"31","author":"M Toichi","year":"1999","unstructured":"Toichi, M. et al. The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol 31, 147\u2013154 (1999).","journal-title":"Int J Psychophysiol"},{"key":"BFsrep07394_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1192\/bjp.179.2.167","volume":"179","author":"H Cohen","year":"2001","unstructured":"Cohen, H., Loewenthal, U., Matar, M. & Kotler, M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry 179, 167\u2013171 (2001).","journal-title":"Br J Psychiatry"},{"key":"BFsrep07394_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s002130050520","volume":"135","author":"T Rechlin","year":"1998","unstructured":"Rechlin, T., Beck, G., Weis, M. & Kaschka, W. P. Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients. Psychopharmacology (Berl) 135, 338\u2013341 (1998).","journal-title":"Psychopharmacology (Berl)"},{"key":"BFsrep07394_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00004850-200411000-00002","volume":"19","author":"K Mann","year":"2004","unstructured":"Mann, K. et al. Heart rate variability during sleep in patients with schizophrenia treated with olanzapine. Int Clin Psychopharmacol 19, 325\u2013330 (2004).","journal-title":"Int Clin Psychopharmacol"},{"key":"BFsrep07394_CR18","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/JCP.0b013e31818a6d25","volume":"28","author":"KJ Bar","year":"2008","unstructured":"Bar, K. J. et al. Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia. J Clin Psychopharmacol 28, 694\u2013698 (2008).","journal-title":"J Clin Psychopharmacol"},{"key":"BFsrep07394_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/026988110201600410","volume":"16","author":"B Silke","year":"2002","unstructured":"Silke, B., Campbell, C. & King, D. J. The potential cardiotoxicity of antipsychotic drugs as assessed by heart rate variability. J Psychopharmacol 16, 355\u2013360 (2002).","journal-title":"J Psychopharmacol"},{"key":"BFsrep07394_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.schres.2013.01.014","volume":"146","author":"VH Srihari","year":"2013","unstructured":"Srihari, V. H. et al. Cardiovascular mortality in schizophrenia: defining a critical period for prevention. Schizophr Res 146, 64\u201368 (2013).","journal-title":"Schizophr Res"},{"key":"BFsrep07394_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.110.163147","volume":"57","author":"T Adachi","year":"2011","unstructured":"Adachi, T. et al. Effect of weight gain on cardiac autonomic control during wakefulness and sleep. Hypertension 57, 723\u2013730 (2011).","journal-title":"Hypertension"},{"key":"BFsrep07394_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/S0002-9149(99)00066-1","volume":"83","author":"K Karason","year":"1999","unstructured":"Karason, K., Molgaard, H., Wikstrand, J. & Sjostrom, L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 83, 1242\u20131247 (1999).","journal-title":"Am J Cardiol"},{"key":"BFsrep07394_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/14737175.3.1.59","volume":"3","author":"J Anath","year":"2003","unstructured":"Anath, J. et al. Weight gain associated with atypical antipsychotic drugs: mechanisms and management. Expert Rev Neurother 3, 59\u201368 (2003).","journal-title":"Expert Rev Neurother"},{"key":"BFsrep07394_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-244X-8-78","volume":"8","author":"I Lipkovich","year":"2008","unstructured":"Lipkovich, I., Jacobson, J. G., Hardy, T. A. & Hoffmann, V. P. Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder. BMC Psychiatry 8, 78 (2008).","journal-title":"BMC Psychiatry"},{"key":"BFsrep07394_CR25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/1469-8986.00072","volume":"40","author":"M Valkonen-Korhonen","year":"2003","unstructured":"Valkonen-Korhonen, M. et al. Heart rate variability in acute psychosis. Psychophysiology 40, 716\u2013726 (2003).","journal-title":"Psychophysiology"},{"key":"BFsrep07394_CR26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/ajp.156.11.1835","volume":"156","author":"KE Bryden","year":"1999","unstructured":"Bryden, K. E. & Kopala, L. C. Body mass index increase of 58% associated with olanzapine. Am J Psychiatry 156, 1835\u20131836 (1999).","journal-title":"Am J Psychiatry"},{"key":"BFsrep07394_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.psychres.2011.07.008","volume":"189","author":"WV Bobo","year":"2011","unstructured":"Bobo, W. V., Bonaccorso, S., Jayathilake, K. & Meltzer, H. Y. Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder. Psychiatry Res 189, 200\u2013207 (2011).","journal-title":"Psychiatry Res"},{"key":"BFsrep07394_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/01.RES.59.2.178","volume":"59","author":"M Pagani","year":"1986","unstructured":"Pagani, M. et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59, 178\u2013193 (1986).","journal-title":"Circ Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07394","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:50:30Z","timestamp":1672984230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep07394"],"URL":"https:\/\/doi.org\/10.1038\/srep07394","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,9]]},"assertion":[{"value":"8 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7394"}}